Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?
Abstract Objective A proliferation-inducing ligand (APRIL) is a new member of the tumour necrosis factor family which is intimately connected to the regulation of cellular pathways. The aim of this study was to assess serum concentrations of APRIL in systemic sclerosis patients, and to correlate the...
Gespeichert in:
Veröffentlicht in: | Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2011-01, Vol.78 (1), p.56-61 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 61 |
---|---|
container_issue | 1 |
container_start_page | 56 |
container_title | Joint, bone, spine : revue du rhumatisme |
container_volume | 78 |
creator | Bassyouni, Iman H Azab, Noha A El-Dakrony, El-Hussein M Fawzi, Marwa M.T Ghanoum, Randa Bassyouni, Rasha H |
description | Abstract Objective A proliferation-inducing ligand (APRIL) is a new member of the tumour necrosis factor family which is intimately connected to the regulation of cellular pathways. The aim of this study was to assess serum concentrations of APRIL in systemic sclerosis patients, and to correlate them with the main clinical and serological features of the disease. Methods Sera from 35 patients with systemic sclerosis, 25 had limited cutaneous and 10 had diffuse cutaneous subtypes, and 35 normal healthy subjects were assayed for APRIL by Enzyme Linked Immunosorbant Assay. Demographic, clinical, autoantibodies and serological data were prospectively assessed. Results Serum APRIL concentrations were higher in patients with systemic sclerosis and in both its subtypes compared to the healthy controls ( p < 0.0001 in all). Patients with elevated APRIL levels had significantly higher incidences of myositis than those with normal levels ( p = 0.04). We did not find significant differences in other organ involvement prevalence between systemic sclerosis patients with elevated vs. normal APRIL levels. In addition, the frequencies of autoantibodies (i.e., anti-topoisomerase I, anti-centromere) were comparable between both groups. Serum APRIL levels were correlated with serum γ-globulins concentrations ( r = 0.404, p = 0.016) but not with C-reactive protein, skin score, nor pulmonary functions. Serum APRIL was also correlated with creatine kinase levels only in systemic sclerosis patients with myositis ( r = 0.786, p = 0.02). Conclusion Our preliminary results suggest increased serum APRIL levels in systemic sclerosis patients, particularly in those associated with myositis and hypergammaglobinemia. To confirm our results, we propose that larger scale, multicentre studies with longer evaluation periods are needed. |
doi_str_mv | 10.1016/j.jbspin.2010.05.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954612565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1297319X10001582</els_id><sourcerecordid>840355393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-b4039886fe357e34759a3648f27cc14d1a4f6085d29e36723c46cf247a9388323</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEoqXwDxDyjVMWfyYOB1BVlQ-pEkiAxM3yOpMyi-MsnqRoj_xzvKRw4NKTv555xzPvVNVTwTeCi-bFbrPb0h7TRvJyxc2Gc32vOhVta-tWGn2_7GXX1kp0X0-qR0Q7zrmSpnlYnUhuuk4LfVr9uoxw42foGUFeRlZOEIlNA_Nsn6eIA2Q_45RqTP0SMF2ziNc-9QwT25cXSDOxnzh_Y3SgGUYMjEKEPBHSS_ZxIsJtBOaJpoB_lFZ6PBRiRnr9uHow-Ejw5HY9q768ufx88a6--vD2_cX5VR20tnO91Vx11jYDKNOC0q3pvGq0HWQbgtC98HpouDW97EA1rVRBN2GQuvWdslZJdVY9X3VLWT8WoNmNSAFi9AmmhVxndCNKe8ydpC1fMUZ1qpB6JUOplzIMbp9x9PngBHdHl9zOrS65o0uOG1dcKmHPbhMs2xH6f0F_bSnAqxUoXsANQnYUSqcD9JghzK6f8K4M_wuEiAmDj9_hALSblpxKs51wJB13n46TchwUUWZEGCvVb0BKu8k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>840355393</pqid></control><display><type>article</type><title>Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Bassyouni, Iman H ; Azab, Noha A ; El-Dakrony, El-Hussein M ; Fawzi, Marwa M.T ; Ghanoum, Randa ; Bassyouni, Rasha H</creator><creatorcontrib>Bassyouni, Iman H ; Azab, Noha A ; El-Dakrony, El-Hussein M ; Fawzi, Marwa M.T ; Ghanoum, Randa ; Bassyouni, Rasha H</creatorcontrib><description>Abstract Objective A proliferation-inducing ligand (APRIL) is a new member of the tumour necrosis factor family which is intimately connected to the regulation of cellular pathways. The aim of this study was to assess serum concentrations of APRIL in systemic sclerosis patients, and to correlate them with the main clinical and serological features of the disease. Methods Sera from 35 patients with systemic sclerosis, 25 had limited cutaneous and 10 had diffuse cutaneous subtypes, and 35 normal healthy subjects were assayed for APRIL by Enzyme Linked Immunosorbant Assay. Demographic, clinical, autoantibodies and serological data were prospectively assessed. Results Serum APRIL concentrations were higher in patients with systemic sclerosis and in both its subtypes compared to the healthy controls ( p < 0.0001 in all). Patients with elevated APRIL levels had significantly higher incidences of myositis than those with normal levels ( p = 0.04). We did not find significant differences in other organ involvement prevalence between systemic sclerosis patients with elevated vs. normal APRIL levels. In addition, the frequencies of autoantibodies (i.e., anti-topoisomerase I, anti-centromere) were comparable between both groups. Serum APRIL levels were correlated with serum γ-globulins concentrations ( r = 0.404, p = 0.016) but not with C-reactive protein, skin score, nor pulmonary functions. Serum APRIL was also correlated with creatine kinase levels only in systemic sclerosis patients with myositis ( r = 0.786, p = 0.02). Conclusion Our preliminary results suggest increased serum APRIL levels in systemic sclerosis patients, particularly in those associated with myositis and hypergammaglobinemia. To confirm our results, we propose that larger scale, multicentre studies with longer evaluation periods are needed.</description><identifier>ISSN: 1297-319X</identifier><identifier>EISSN: 1778-7254</identifier><identifier>DOI: 10.1016/j.jbspin.2010.05.004</identifier><identifier>PMID: 20599414</identifier><language>eng</language><publisher>France: Elsevier SAS</publisher><subject>A proliferation-inducing ligand (APRIL) ; Adult ; Aged ; C-Reactive Protein - metabolism ; gamma-Globulins - metabolism ; Humans ; Hypergammaglobulinemia - epidemiology ; Hypergammaglobulinemia - immunology ; Hypergammaglobulinemia - metabolism ; Incidence ; Internal Medicine ; Lung Diseases - epidemiology ; Lung Diseases - immunology ; Lung Diseases - metabolism ; Middle Aged ; Myositis ; Myositis - epidemiology ; Myositis - immunology ; Myositis - metabolism ; Prevalence ; Prospective Studies ; Rheumatology ; Scleroderma, Systemic - epidemiology ; Scleroderma, Systemic - immunology ; Scleroderma, Systemic - metabolism ; Systemic sclerosis ; Tumor Necrosis Factor Ligand Superfamily Member 13 - blood ; Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology ; Young Adult</subject><ispartof>Joint, bone, spine : revue du rhumatisme, 2011-01, Vol.78 (1), p.56-61</ispartof><rights>Société française de rhumatologie</rights><rights>2010 Société française de rhumatologie</rights><rights>Copyright © 2010 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-b4039886fe357e34759a3648f27cc14d1a4f6085d29e36723c46cf247a9388323</citedby><cites>FETCH-LOGICAL-c448t-b4039886fe357e34759a3648f27cc14d1a4f6085d29e36723c46cf247a9388323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jbspin.2010.05.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20599414$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bassyouni, Iman H</creatorcontrib><creatorcontrib>Azab, Noha A</creatorcontrib><creatorcontrib>El-Dakrony, El-Hussein M</creatorcontrib><creatorcontrib>Fawzi, Marwa M.T</creatorcontrib><creatorcontrib>Ghanoum, Randa</creatorcontrib><creatorcontrib>Bassyouni, Rasha H</creatorcontrib><title>Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?</title><title>Joint, bone, spine : revue du rhumatisme</title><addtitle>Joint Bone Spine</addtitle><description>Abstract Objective A proliferation-inducing ligand (APRIL) is a new member of the tumour necrosis factor family which is intimately connected to the regulation of cellular pathways. The aim of this study was to assess serum concentrations of APRIL in systemic sclerosis patients, and to correlate them with the main clinical and serological features of the disease. Methods Sera from 35 patients with systemic sclerosis, 25 had limited cutaneous and 10 had diffuse cutaneous subtypes, and 35 normal healthy subjects were assayed for APRIL by Enzyme Linked Immunosorbant Assay. Demographic, clinical, autoantibodies and serological data were prospectively assessed. Results Serum APRIL concentrations were higher in patients with systemic sclerosis and in both its subtypes compared to the healthy controls ( p < 0.0001 in all). Patients with elevated APRIL levels had significantly higher incidences of myositis than those with normal levels ( p = 0.04). We did not find significant differences in other organ involvement prevalence between systemic sclerosis patients with elevated vs. normal APRIL levels. In addition, the frequencies of autoantibodies (i.e., anti-topoisomerase I, anti-centromere) were comparable between both groups. Serum APRIL levels were correlated with serum γ-globulins concentrations ( r = 0.404, p = 0.016) but not with C-reactive protein, skin score, nor pulmonary functions. Serum APRIL was also correlated with creatine kinase levels only in systemic sclerosis patients with myositis ( r = 0.786, p = 0.02). Conclusion Our preliminary results suggest increased serum APRIL levels in systemic sclerosis patients, particularly in those associated with myositis and hypergammaglobinemia. To confirm our results, we propose that larger scale, multicentre studies with longer evaluation periods are needed.</description><subject>A proliferation-inducing ligand (APRIL)</subject><subject>Adult</subject><subject>Aged</subject><subject>C-Reactive Protein - metabolism</subject><subject>gamma-Globulins - metabolism</subject><subject>Humans</subject><subject>Hypergammaglobulinemia - epidemiology</subject><subject>Hypergammaglobulinemia - immunology</subject><subject>Hypergammaglobulinemia - metabolism</subject><subject>Incidence</subject><subject>Internal Medicine</subject><subject>Lung Diseases - epidemiology</subject><subject>Lung Diseases - immunology</subject><subject>Lung Diseases - metabolism</subject><subject>Middle Aged</subject><subject>Myositis</subject><subject>Myositis - epidemiology</subject><subject>Myositis - immunology</subject><subject>Myositis - metabolism</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Rheumatology</subject><subject>Scleroderma, Systemic - epidemiology</subject><subject>Scleroderma, Systemic - immunology</subject><subject>Scleroderma, Systemic - metabolism</subject><subject>Systemic sclerosis</subject><subject>Tumor Necrosis Factor Ligand Superfamily Member 13 - blood</subject><subject>Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology</subject><subject>Young Adult</subject><issn>1297-319X</issn><issn>1778-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk1v1DAQhiMEoqXwDxDyjVMWfyYOB1BVlQ-pEkiAxM3yOpMyi-MsnqRoj_xzvKRw4NKTv555xzPvVNVTwTeCi-bFbrPb0h7TRvJyxc2Gc32vOhVta-tWGn2_7GXX1kp0X0-qR0Q7zrmSpnlYnUhuuk4LfVr9uoxw42foGUFeRlZOEIlNA_Nsn6eIA2Q_45RqTP0SMF2ziNc-9QwT25cXSDOxnzh_Y3SgGUYMjEKEPBHSS_ZxIsJtBOaJpoB_lFZ6PBRiRnr9uHow-Ejw5HY9q768ufx88a6--vD2_cX5VR20tnO91Vx11jYDKNOC0q3pvGq0HWQbgtC98HpouDW97EA1rVRBN2GQuvWdslZJdVY9X3VLWT8WoNmNSAFi9AmmhVxndCNKe8ydpC1fMUZ1qpB6JUOplzIMbp9x9PngBHdHl9zOrS65o0uOG1dcKmHPbhMs2xH6f0F_bSnAqxUoXsANQnYUSqcD9JghzK6f8K4M_wuEiAmDj9_hALSblpxKs51wJB13n46TchwUUWZEGCvVb0BKu8k</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Bassyouni, Iman H</creator><creator>Azab, Noha A</creator><creator>El-Dakrony, El-Hussein M</creator><creator>Fawzi, Marwa M.T</creator><creator>Ghanoum, Randa</creator><creator>Bassyouni, Rasha H</creator><general>Elsevier SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QP</scope></search><sort><creationdate>20110101</creationdate><title>Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?</title><author>Bassyouni, Iman H ; Azab, Noha A ; El-Dakrony, El-Hussein M ; Fawzi, Marwa M.T ; Ghanoum, Randa ; Bassyouni, Rasha H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-b4039886fe357e34759a3648f27cc14d1a4f6085d29e36723c46cf247a9388323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>A proliferation-inducing ligand (APRIL)</topic><topic>Adult</topic><topic>Aged</topic><topic>C-Reactive Protein - metabolism</topic><topic>gamma-Globulins - metabolism</topic><topic>Humans</topic><topic>Hypergammaglobulinemia - epidemiology</topic><topic>Hypergammaglobulinemia - immunology</topic><topic>Hypergammaglobulinemia - metabolism</topic><topic>Incidence</topic><topic>Internal Medicine</topic><topic>Lung Diseases - epidemiology</topic><topic>Lung Diseases - immunology</topic><topic>Lung Diseases - metabolism</topic><topic>Middle Aged</topic><topic>Myositis</topic><topic>Myositis - epidemiology</topic><topic>Myositis - immunology</topic><topic>Myositis - metabolism</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Rheumatology</topic><topic>Scleroderma, Systemic - epidemiology</topic><topic>Scleroderma, Systemic - immunology</topic><topic>Scleroderma, Systemic - metabolism</topic><topic>Systemic sclerosis</topic><topic>Tumor Necrosis Factor Ligand Superfamily Member 13 - blood</topic><topic>Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bassyouni, Iman H</creatorcontrib><creatorcontrib>Azab, Noha A</creatorcontrib><creatorcontrib>El-Dakrony, El-Hussein M</creatorcontrib><creatorcontrib>Fawzi, Marwa M.T</creatorcontrib><creatorcontrib>Ghanoum, Randa</creatorcontrib><creatorcontrib>Bassyouni, Rasha H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Calcium & Calcified Tissue Abstracts</collection><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bassyouni, Iman H</au><au>Azab, Noha A</au><au>El-Dakrony, El-Hussein M</au><au>Fawzi, Marwa M.T</au><au>Ghanoum, Randa</au><au>Bassyouni, Rasha H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?</atitle><jtitle>Joint, bone, spine : revue du rhumatisme</jtitle><addtitle>Joint Bone Spine</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>78</volume><issue>1</issue><spage>56</spage><epage>61</epage><pages>56-61</pages><issn>1297-319X</issn><eissn>1778-7254</eissn><abstract>Abstract Objective A proliferation-inducing ligand (APRIL) is a new member of the tumour necrosis factor family which is intimately connected to the regulation of cellular pathways. The aim of this study was to assess serum concentrations of APRIL in systemic sclerosis patients, and to correlate them with the main clinical and serological features of the disease. Methods Sera from 35 patients with systemic sclerosis, 25 had limited cutaneous and 10 had diffuse cutaneous subtypes, and 35 normal healthy subjects were assayed for APRIL by Enzyme Linked Immunosorbant Assay. Demographic, clinical, autoantibodies and serological data were prospectively assessed. Results Serum APRIL concentrations were higher in patients with systemic sclerosis and in both its subtypes compared to the healthy controls ( p < 0.0001 in all). Patients with elevated APRIL levels had significantly higher incidences of myositis than those with normal levels ( p = 0.04). We did not find significant differences in other organ involvement prevalence between systemic sclerosis patients with elevated vs. normal APRIL levels. In addition, the frequencies of autoantibodies (i.e., anti-topoisomerase I, anti-centromere) were comparable between both groups. Serum APRIL levels were correlated with serum γ-globulins concentrations ( r = 0.404, p = 0.016) but not with C-reactive protein, skin score, nor pulmonary functions. Serum APRIL was also correlated with creatine kinase levels only in systemic sclerosis patients with myositis ( r = 0.786, p = 0.02). Conclusion Our preliminary results suggest increased serum APRIL levels in systemic sclerosis patients, particularly in those associated with myositis and hypergammaglobinemia. To confirm our results, we propose that larger scale, multicentre studies with longer evaluation periods are needed.</abstract><cop>France</cop><pub>Elsevier SAS</pub><pmid>20599414</pmid><doi>10.1016/j.jbspin.2010.05.004</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1297-319X |
ispartof | Joint, bone, spine : revue du rhumatisme, 2011-01, Vol.78 (1), p.56-61 |
issn | 1297-319X 1778-7254 |
language | eng |
recordid | cdi_proquest_miscellaneous_954612565 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | A proliferation-inducing ligand (APRIL) Adult Aged C-Reactive Protein - metabolism gamma-Globulins - metabolism Humans Hypergammaglobulinemia - epidemiology Hypergammaglobulinemia - immunology Hypergammaglobulinemia - metabolism Incidence Internal Medicine Lung Diseases - epidemiology Lung Diseases - immunology Lung Diseases - metabolism Middle Aged Myositis Myositis - epidemiology Myositis - immunology Myositis - metabolism Prevalence Prospective Studies Rheumatology Scleroderma, Systemic - epidemiology Scleroderma, Systemic - immunology Scleroderma, Systemic - metabolism Systemic sclerosis Tumor Necrosis Factor Ligand Superfamily Member 13 - blood Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology Young Adult |
title | Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T22%3A07%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20serum%20levels%20of%20a%20proliferation-inducing%20ligand%20in%20patients%20with%20systemic%20sclerosis:%20Possible%20association%20with%20myositis?&rft.jtitle=Joint,%20bone,%20spine%20:%20revue%20du%20rhumatisme&rft.au=Bassyouni,%20Iman%20H&rft.date=2011-01-01&rft.volume=78&rft.issue=1&rft.spage=56&rft.epage=61&rft.pages=56-61&rft.issn=1297-319X&rft.eissn=1778-7254&rft_id=info:doi/10.1016/j.jbspin.2010.05.004&rft_dat=%3Cproquest_cross%3E840355393%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=840355393&rft_id=info:pmid/20599414&rft_els_id=1_s2_0_S1297319X10001582&rfr_iscdi=true |